The Promise of Machine Learning-Based Population Screening for Hepatocellular Carcinoma
1The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Discovery
|July 1, 2026
Abstract:
Clusmann and colleagues developed PRE-Screen-HCC, an interpretable machine learning framework that leverages multimodal clinical data from 2 population-scale cohorts to stratify hepatocellular carcinoma risk, significantly outperforming existing risk scores and demonstrating robustness across diverse ethnic subgroups. See related article by Clusmann et al., p. 1304.

